Research Study

SAPPHIRE: A randomized, masked, controlled trial to study the safety and efficacy of suprachoroidal CLS-TA in conjunction with intravitreal aflibercept in subjects with retinal vein occlusion
Principal Investigator 
Andrew Merkur

Overview

Body Locations and Systems 
Macular Edema
ClinicalTrials.gov# 
NCT02980874
Status 
Recruiting
Study Start/End 
Jan 8, 2018 to Jun 30, 2019
Locations 
Vancouver General Hospital
Name/Title 
Aleksandra Kuzmanovic, Research Coordinator
Phone 
604-875-4253
Purpose of Study 

The purpose of this study is to demonstrate the safety and efficacy of  suprachoroidal injection of CLS-TA (Triamcinolone Acetonide) in conjunction with intravitreal injection of aflibercept in subjects with macular edema following retinal vein occlusion.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.